Health Care
More on Health Care
| Washington, D.C. - On Thursday, April 29th at 1:00 P.M. ET, the House Judiciary Subcommittee on Antitrust, Commercial, and Administrative Law will hold a hearing entitled, "Treating the Problem: Addressing Anticompetitive Conduct and Consolidation in Health Care Markets." The hearing will examine proposals to lower pharmaceutical drug prices and address consolidation in the markets for hospital care, health insurance, prescription drugs and other health care products and services. |
Washington, D.C. (Apr. 13, 2021)—Today, Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, and Committee Member Rep. Ayanna Pressley, Chair of the Pro-Choice Caucus's Abortion Rights and Access Task Force, issued the following statement in response to the Food and Drug Administration's (FDA) decision to temporarily lift the medically unnecessary in-person dispensing requirement for mifepristone for the duration of the COVID-19 public health emergency:
Washington D.C. – Today, Reps. Adam Schiff (D-CA) and Carolyn B. Maloney (D-NY), along with Reps. Barbara Lee (D-CA), Mike Quigley (D-IL), Katherine Clark (D-MA), Jamie Raskin (D-MD), Alexandria Ocasio-Cortez (D-NY), Chris Pappas (D-NH), and Ritchie Torres (D-NY) introduced a resolution highlighting the urgent need for nondiscriminatory and equitable blood and blood product donation policies in the United States.
Washington, D.C. – A coalition of congressional leaders from the Senate Committee on Finance and the House Committee on Oversight and Reform today urged the Biden administration to finalize a rule to reform the organ procurement system in the United States.
| Washington, D.C. (Feb. 9, 2021)—Today, Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, and Committee Member Rep. |
| Washington, D.C. (Jan. 13, 2021)—– Today, House Oversight and Reform Committee Chairwoman Carolyn B. Maloney, House Energy and Commerce Committee Chairman Frank Pallone, Jr., House Ways and Means Committee Chairman Richard E. |
Washington, D.C. (Dec. 8, 2020)—Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, sent letters informing lawyers for Dr. Richard Sackler, Mr. David Sackler, Dr. Kathe Sackler, and Mr. Mortimer D.A. Sackler that the Committee will hold a hearing next week on the role of Purdue Pharma and the Sackler family in fueling the opioid epidemic. Purdue CEO Craig Landau has also been invited.